Global News
- All
- AI
- Markets
- Macroeconomics
Smart Beta ETF report for HDV
Smart Beta ETF report for TILT
Smart Beta ETF report for DJD
As tariff tensions ease and investor sentiment improves, global ETFs like ACWI are poised for a rally.
Eurozone economic growth picked up in July, driven by services and stabilising factory activity, suggesting a stronger start to the third quarter. Manufacturing showed signs of recovery, while inflation eased—offering cautious optimism for the bloc’s outl
(Bloomberg) -- Deutsche Bank AG’s shares rose to the highest in a decade after reporting better-than-expected trading results, as Germany’s largest bank continues its recovery under Chief Executive Officer Christian Sewing.Most Read from BloombergTrump Aw
ASML is powering important advancements in artificial intelligence. Alternatively, you can invest in a company like ASML Holding (NASDAQ: ASML), which benefits from the growth of AI, regardless of its application or end use case. Here's why ASML has the m
Electric vehicle giant Tesla and Google parent Alphabet were the first two of the Magnificent Seven to report earnings after the close.
NEW YORK (Reuters) -Massive moves in stocks such as Kohl’s and Opendoor Technologies are raising questions over whether a new wave of meme stock trading is underway and what that signals about risk appetite more broadly. Benchmark equity indexes have touc
The tech giants aren't facing an existential threat, and investors know it.
Stocks surged as a U.S.-Japan trade deal and EU progress boosted optimism ahead of a key tariff deadline. Growth ETFs like RPG, FNY, RFG should rally ahead.
(Bloomberg) -- Gold extended a decline as progress in talks between the US and key trading partners eased demand for haven assets.Most Read from BloombergTrump Awards $1.26 Billion Contract to Build Biggest Immigrant Detention Center in USWhy the Federal
This popular income fund has been underperforming, but the reason may be about to change.
Shopify's moat and vast runway for growth make its prospects highly attractive. Axsome Therapeutics has a robust late-stage pipeline that should lead to important approvals. Others understand that the stock market generates excellent returns over the long